18F-FDG

This pharmaceutical product is indicated for use in positron emission tomography (PET) in adults and pediatric population. In oncologic diagnostic procedures it is indicated for diagnosis, staging, monitoring of therapeutic response, detection in case of reasonable suspicion of recurrences. In the cardiologic indication, the diagnostic target is viable myocardial tissue that takes-up glucose but is hypo-perfused. Evaluation of myocardial viability in patients with severe impaired left ventricular function. In the neurologic indication, the interictal glucose hypometabolism is the diagnostic target. Localization of epileptogenic foci in the presurgical evaluation of partial temporal epilepsy and nodular sclerosis. Localization of epileptogenic foci in the presurgical evaluation of partial temporal epilepsy and nodular sclerosis. It is also used for the diagnosis of various forms of dementia (e.g. Alzheimer).